🇺🇸 KRYS — Krystal Biotech, Inc.

Salud Compra fuerte
← Volver

Precio actual

300,88 USD

Máx. histórico

378,15

130 días

Caída desde máximo

-20,43%

Rango 52 semanas

192,52 – 382,54

Variación hoy

+0,21%

Cierre anterior

300,25

Rango de hoy

297,52 – 305,60

Volumen hoy

234.199

Peor caída histórica

-53,42%

01/03/2021 → 26/11/2021

Recuperado en 3 días

Volatilidad anualizada ⓘ

73,03%

Información
Nombre completo
Krystal Biotech, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
295
PER ⓘ
40,88 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
388,22 USD (puede no estar actualizado)
Primera cotización
20/09/2017
Precio actualizado
hace 22 horas
Sobre la empresa

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/03/2021 68,16 70,53 66,93 69,19 +0,36% 5,28% 68.200
26/03/2021 71,77 71,77 66,77 68,94 -3,16% 6,97% 107.000
25/03/2021 67,89 73,07 67,61 71,19 +2,89% 8,04% 188.200
24/03/2021 73,82 77,30 68,63 69,19 -5,02% 11,75% 116.800
23/03/2021 76,19 76,19 71,17 72,85 -5,74% 6,59% 96.500
22/03/2021 76,79 79,84 75,76 77,29 +0,95% 5,31% 73.500
19/03/2021 76,68 78,75 75,54 76,56 +0,08% 4,19% 488.900
18/03/2021 80,57 81,43 76,16 76,50 -6,67% 6,53% 105.700
17/03/2021 80,66 83,01 79,38 81,97 -0,04% 4,50% 95.400
16/03/2021 81,85 84,53 80,31 82,00 +0,58% 5,16% 90.700
15/03/2021 82,76 85,05 80,56 81,53 -1,55% 5,43% 72.600
12/03/2021 84,04 85,21 82,21 82,81 -2,14% 3,58% 100.000
11/03/2021 80,00 84,85 79,18 84,62 +6,67% 7,09% 158.000
10/03/2021 75,54 79,87 75,50 79,33 +6,08% 5,79% 209.400
09/03/2021 71,63 78,06 71,63 74,78 +6,68% 8,98% 188.900
08/03/2021 72,98 75,08 68,87 70,10 -3,63% 8,51% 112.900
05/03/2021 72,16 73,22 67,99 72,74 +1,52% 7,25% 219.100
04/03/2021 82,80 85,00 70,91 71,65 -13,91% 17,02% 269.000
03/03/2021 83,71 85,68 81,25 83,23 -1,23% 5,29% 124.900
02/03/2021 85,46 86,79 81,36 84,27 -1,39% 6,35% 137.800
01/03/2021 80,52 87,29 80,52 85,46 +8,33% 8,40% 222.700
26/02/2021 78,58 80,60 76,50 78,89 +0,01% 5,22% 125.100
25/02/2021 80,04 81,56 77,77 78,88 -2,75% 4,74% 184.900
24/02/2021 75,94 81,80 75,94 81,11 +5,94% 7,72% 181.000
23/02/2021 75,15 78,53 72,81 76,56 -0,48% 7,61% 240.800
22/02/2021 75,82 78,20 74,82 76,93 -0,06% 4,46% 101.600
19/02/2021 74,58 79,00 74,58 76,98 +3,22% 5,93% 132.500
18/02/2021 74,36 75,60 73,42 74,58 -0,94% 2,93% 170.600
17/02/2021 71,77 76,84 71,32 75,29 +3,43% 7,68% 236.100
16/02/2021 70,65 75,86 69,60 72,79 +3,85% 8,86% 242.400